CAD 0.03
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 559.87 Thousand | 1.09 Million | 682.29 Thousand | 1.04 Million | 705.55 Thousand | 1.51 Million |
Selling, General and Administrative Expenses | 514.63 Thousand | 1.03 Million | 597.63 Thousand | 994.4 Thousand | 683.03 Thousand | 1.43 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 162.5 Thousand | 5315.00 | 78.6 Thousand | 25 Thousand | 25.12 Thousand |
Cost and Expenses | 559.87 Thousand | 1.09 Million | 682.29 Thousand | 1.04 Million | 705.55 Thousand | 1.51 Million |
Operating Income | -514.63 Thousand | 1.27 Million | -861.4 Thousand | -753.02 Thousand | -573.19 Thousand | -1.64 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | 2.37 Million | -179.39 Thousand | 289.09 Thousand | 132.24 Thousand | -128.2 Thousand |
Earnings before Tax | 637.36 Thousand | -3.3 Million | -497.87 Thousand | -1.25 Million | -837.9 Thousand | -1.36 Million |
Net Income | 637.36 Thousand | -3.3 Million | -497.87 Thousand | -1.25 Million | -837.9 Thousand | -1.36 Million |
Earnings Per Share Basic | 0.00 | -0.02 | -0.00 | -0.01 | -0.01 | -0.02 |
Earnings Per Share Diluted | 0.00 | -0.02 | -0.00 | -0.01 | -0.01 | -0.02 |
Weighted Average Shares Outstanding | 263.81 Million | 216.02 Million | 143 Million | 98.24 Million | 59.58 Million | 58.2 Million |
Weighted Average Shares Outstanding (Diluted) | 263.79 Million | 216.02 Million | 143 Million | 98.24 Million | 59.58 Million | 58.2 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | 1.15 Million | -2.34 Million | -236.6 Thousand | -753.02 Thousand | -573.19 Thousand | -1.36 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 162.62 Thousand | 230.26 Thousand | 156.52 Thousand | 864.63 Thousand | 152.85 Thousand | 278.1 Thousand |
Selling, General and Administrative Expenses | 141.26 Thousand | 230.26 Thousand | 156.52 Thousand | - | 139.16 Thousand | 265.36 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 161.48 Thousand | 460.34 Thousand | 504.95 Thousand | - | 800.19 Thousand | 522.5 Thousand |
Cost and Expenses | 162.62 Thousand | 230.26 Thousand | 156.52 Thousand | 864.63 Thousand | 152.85 Thousand | 278.1 Thousand |
Operating Income | -171.25 Thousand | -230.26 Thousand | -156.53 Thousand | -864.63 Thousand | -206.62 Thousand | -82.77 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | -43.27 Thousand | -43.81 Thousand | -167.89 Thousand | -83.48 Thousand | 195.17 Thousand |
Earnings before Tax | 47.5 Thousand | 218.73 Thousand | 232.73 Thousand | 637.36 Thousand | 730.7 Thousand | 49.08 Thousand |
Net Income | 47.5 Thousand | 218.73 Thousand | 232.73 Thousand | 637.36 Thousand | 730.7 Thousand | 49.08 Thousand |
Earnings Per Share Basic | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 |
Earnings Per Share Diluted | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 |
Weighted Average Shares Outstanding | 277.12 Million | 276.96 Million | 277.12 Million | 263.79 Million | 276.96 Million | 276.96 Million |
Weighted Average Shares Outstanding (Diluted) | 277.12 Million | 276.96 Million | 277.12 Million | 263.79 Million | 276.96 Million | 276.96 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -171.25 Thousand | -230.26 Thousand | -156.53 Thousand | - | -206.62 Thousand | -82.77 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
CMCL
THKLY
CUB
INDIAGLYCO
0KC4
PIDILITIND